logo

For the Inventor, By the Inventor

Shizuoka, Japan

Shinji Morioka

This inventor holds 5 USPTO granted patents. Top assignee: Japan Tobacco Inc.. Active years: 1998-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Morioka. Retrieved from https://idiyas.com/inventor/shinji-morioka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 80.0

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Iwata-gun, JP (1998)
  • Tokyo, JP (1999 - 2001)
  • Shizuoka, JP (1998 - 2006)

Company Filing History:

goldMedal5 out of 1,067 
 
Japan Tobacco Inc.
 patents

Years Active: 1998-2006

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6998477 - Nucleic acid fragment, recombinant vector containing the same and method of promoting the expression of structural genes by using the same (2006-02-14),
2. 6214578 - Method for the expressing foreign genes and vectors therefor (2001-04-10),
3. 5973226 - Method of changing the composition of the phospholipid produced by the (1999-10-26),
4. 5801016 - DNA fragment, recombinant vector containing the same and method for (1998-09-01),
5. 5747327 - Phospholipase D gene originated from plant (1998-05-05),

Title: Shinji Morioka: Innovator in Nucleic Acid Technology

Introduction

Shinji Morioka is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid technology. With a total of 5 patents to his name, Morioka's work has advanced the understanding and application of genetic engineering.

Latest Patents

Morioka's latest patents include a novel nucleic acid fragment and a recombinant vector designed to promote the expression of structural genes. The first patent discloses a nucleic acid fragment that exhibits high activity in promoting the expression of downstream structural genes. This invention provides a method for enhancing gene expression using specific nucleotide sequences. The second patent outlines a method for expressing foreign genes more effectively than conventional techniques. This method involves inserting foreign genes downstream of a promoter and utilizing intron-originated DNA fragments to enhance expression.

Career Highlights

Shinji Morioka is currently employed at Japan Tobacco Inc., where he continues to innovate in the field of biotechnology. His work has not only contributed to the scientific community but has also had practical applications in various industries.

Collaborations

Morioka has collaborated with notable colleagues, including Jun Ueki and Yoshiki Kuraya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shinji Morioka's contributions to nucleic acid technology exemplify the impact of innovative thinking in biotechnology. His patents reflect a commitment to advancing genetic engineering and enhancing gene expression methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…